Global Airway Management Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Supraglottic, Infraglottic, Resuscitators, & Laryngoscopes), By Application (Anesthesia and Emergency Medicine), By End User (Hospitals & Ambulatory Surgical Centers, Homecare, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032
Industry: HealthcareGlobal Airway Management Devices Market Insights Forecasts to 2032
- The Global Airway Management Devices Market Size was valued at USD 1.8 Billion in 2022.
- The Market Size is Growing at a CAGR of 6.8% from 2022 to 2032.
- The worldwide Airway Management Devices Market size is expected to reach USD 3.5 Billion by 2032.
- Asia Pacific is expected to grow the fastest during the forecast period.
Get more details on this report -
The Global Airway Management Devices Market Size is expected to reach USD 3.5 Billion by 2032, at a CAGR of 6.8% during the forecast period 2022 to 2032.
Market Overview
An airway management device is a combination of medical techniques used to maintain patients' airways free. This device maintains an open channel in patients, allowing gas exchange between the lungs and the environment. Devices such as oropharyngeal airways, nasopharyngeal airways, laryngeal mask airways, and tracheal incubation are used in hospitals to give anesthetic airways to patients. These devices are utilized in several contexts, including anesthesia, cardiopulmonary resuscitation, emergency medicine, neonatology, and many more. It has uses in neonatology for treating newborns' airways, and the rising prevalence of premature delivery may entail the necessity for airway management. Airway management refers to the examination, planning, and procedures required for the patient's breathing or ventilation to be maintained or restored. Various airway management devices, such as the NPA (nasopharyngeal airway), OPA (oropharyngeal airway), and ETA (endotracheal airway), are used to open or maintain the airway.
Report Coverage
This research report categorizes the global airway management devices market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global airway management devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global airway management devices market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.
Global Airway Management Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022 : | USD 1.8 Billion |
Forecast Period: | 2022-2032 |
Forecast Period CAGR 2022-2032 : | 6.8% |
2032 Value Projection: | USD 3.5 Billion |
Historical Data for: | 2018-2021 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 130 |
Segments covered: | By Product, By Application, By End User, By Region |
Companies covered:: | Boston Scientific Corporation, Coloplast Group, E.M.S., Lumenis Be Ltd, Olympus Corporation, Dornier MedTech., Richard Wolf GmbH, Siemens, Medtronic, Smiths Medical, Teleflex Incorporated, Ambu A/S, Verathon Inc., SourceMark, SunMed, KARL STORZ, Flexicare (Group) Limited, TRACOE Medical GmbH, Vyaire Medical |
Pitfalls & Challenges: | COVID-19 Empact,Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The rising incidence of respiratory disorders is expected to be one of the market's major driving factors. According to WHO estimates, 65 million individuals have moderate-to-severe COPD. Furthermore, COPD is expected to be the third largest cause of mortality worldwide. Also, this high incidence, along with an increase in anesthetic consumption due to an increase in operations, is likely to drive demand for sophisticated devices, positively impacting the overall market growth. The growing demand for emergency treatment for long-term illnesses, as well as extended therapy for lung disorders in children and adults, is likely to fuel market expansion. Moreover, In the current environment, growing awareness of inadequate ventilation and the introduction of relatively advanced procedures for preoperative airway examination is projected to broaden the possibility for product penetration in the future years.
Restraining Factors
The global need for effective treatment options for respiratory illnesses is expanding. Intubation with airway control devices is frequently life-saving. However, long-term usage of these devices, may offer serious dangers and possible problems such as regurgitation and aspiration of stomach contents, compression of vascular structures, trauma, and nerve injury. Although the occurrence of such consequences, such as trauma and nerve damage, is very minimal, the use of some medical devices may pose considerable dangers.
Market Segmentation
- In 2022, the supraglottic segment is dominating the market with the largest market share over the forecast period.
Based on the product, the global airway management devices market is segmented into supraglottic, infraglottic, resuscitators, & laryngoscopes. Throughout these segments, the supraglottic segment is influencing the market with the largest revenue share during the forecast period. The increased demand for these items is thought to be a result of the accompanying advantages. The most major advantage is the ease of tracheal installation, which results in improved patient safety and is thought to influence patient and anesthesiologist preference for these devices. Furthermore, supraglottic devices, such as indirect video laryngoscopes, are increasingly being used in a wide variety of clinical applications and also eliminate the necessity for tracheal intubation, fueling the expansion of this market.
- In 2022, the anesthesia segment is influencing the largest market share over the forecast period.
Based on the application, the global airway management devices market is classified into anesthesia and emergency medicine. Among these segments, the anesthesia segment is dominating the market. due to anesthesiologists' favor and use of these devices in surgical operational procedures. The increased usage is thought to be due to excellent efficiency in airway clearing and appropriate breathing without compromising patient safety during operational operations. Furthermore, a rising number of product launches and acquisition tactics used by key market competitors are thought to be responsible for this segment's larger market share.
- In 2022, the hospital segment is dominating the largest market share over the forecast period.
On the basis of end users, the global airway management devices market is classified into hospitals & ambulatory surgical centers, homecare, and others. Among these segments, the hospital segment is leading the market due to the high patient turnover, frequent readmissions, and enormous procedure volumes. Furthermore, supported infrastructure enables effective airway management operational operations, resulting in a larger proportion. Furthermore, increased government programs targeted at boosting safety and preventing adverse occurrences are major contributors to the segment's large share.
Regional Segment Analysis of the airway management devices market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America dominated the market with the largest market revenue during the forecast period
Get more details on this report -
North America is dominating the significant market growth during the forecast period owing to the supporting government initiatives and extensive application of practice recommendations produced by healthcare organizations existing in this area are some of the primary elements responsible for this segment's high share. The overwhelming share can also be linked to the region's high prevalence of serious respiratory disorders.
Asia Pacific is expected to experience high revenue market growth during the forecast period due to the increased outsourcing of device production to Asia Pacific nations such as India and China, this area is expected to develop at an exponential rate throughout the projection period. Furthermore, significant R&D expenditure by global competitors and the existence of untapped potential in this area act as strong growth rendering drivers.
Competitive Analysis
The report offers the appropriate analysis of the key organizations/companies involved within the global airway management devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Boston Scientific Corporation
- Coloplast Group
- E.M.S.
- Lumenis Be Ltd
- Olympus Corporation
- Dornier MedTech.
- Richard Wolf GmbH
- Siemens
- Medtronic
- Smiths Medical
- Teleflex Incorporated
- Ambu A/S
- Verathon Inc.
- SourceMark
- SunMed
- KARL STORZ
- Flexicare (Group) Limited
- TRACOE Medical GmbH
- Vyaire Medical
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In January 2022, Intersurgical Ltd announced the acquisition of Pulmodyne, Inc., a U.S., and Malaysian-based manufacturer, which would strengthen the company's efforts to develop high-quality new airway and respiratory solutions for use in prehospital, emergency care, critical care, and at home. The purchase will also enable Intersurgical to establish a more elaborate presence in the US market and enhance sales of the Pulmodyne ranges via the broad worldwide Intersurgical Ltd network.
- In January 2022, Coloplast A/S bought Atos Medical in 2Coloplast A/S acquired Atos Medical in 2Coloplast A/S purchased Atos Medical to add a new chronic business sector - ENT & Respiratory Care, which will operate as a distinct strategic unit to common Coloplast infrastructure.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Airway Management Devices Market based on the below-mentioned segments:
Global Airway Management Devices Market, By Product
- Supraglottic
- Infraglottic
- Resuscitators
- Laryngoscopes
Global Airway Management Devices Market, By Application
- Anesthesia
- Emergency Medicine
Global Airway Management Devices Market, By End Users
- Hospitals & Ambulatory Surgical Centers
- Homecare
- Others
Airway Management Devices Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?